{"blog": [], "keywords": [{"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "1", "is_major": "N"}, {"value": "Health Insurance and Managed Care", "name": "subject", "rank": "2", "is_major": "N"}], "web_url": "http://www.nytimes.com/2016/10/21/opinion/the-pharma-ceo-who-wants-to-lower-drug-prices.html", "document_type": "article", "byline": {"person": [{"lastname": "BAJAJ", "firstname": "Vikas", "role": "reported", "organization": "", "rank": 1}], "original": "By VIKAS BAJAJ"}, "type_of_material": "Editorial", "multimedia": [{"url": "images/2016/10/21/opinion/21bajajWEB/21bajajWEB-thumbWide.jpg", "legacy": {"wide": "images/2016/10/21/opinion/21bajajWEB/21bajajWEB-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2016/10/21/opinion/21bajajWEB/21bajajWEB-articleLarge.jpg", "legacy": {"xlarge": "images/2016/10/21/opinion/21bajajWEB/21bajajWEB-articleLarge.jpg", "xlargeheight": "400", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 400}, {"url": "images/2016/10/21/opinion/21bajajWEB/21bajajWEB-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/10/21/opinion/21bajajWEB/21bajajWEB-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "Opinion", "word_count": "700", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "Companies can drop prices and still make money, says the chief executive of GlaxoSmithKline.", "pub_date": "2016-10-21T17:03:25+0000", "news_desk": "Editorial", "headline": {"kicker": "Taking Note", "main": "The Pharma C.E.O. Who Wants to Lower Drug Prices", "content_kicker": "Taking Note"}, "print_page": null, "snippet": "Companies can drop prices and still make money, says the chief executive of GlaxoSmithKline....", "_id": "580a4a6495d0e022439c4868", "slideshow_credits": null, "abstract": null}